Objective To investigate the impact of mucosolvan aerosol inhalation on airway management of patients after lung cancer surger-y. Methods A total of 78 patients after lung cancer surgery were randomly divided into the experiment group and the control group,38 cases in each group. Patients in control group adopted ultrasonic inhalation with gentamicin and chymotrypsin, while those in experiment group adopted ultrasonic inhalation mucosolvan. The effects on airwary management were compared between two groups. Results Compared with the control group, the number of sputum suction, the total hospital stay time, the occurrence rate of pulmonary infection and the occurrence rate of drug adverse reaction in experimental group were decreased significantly( P <0. 05 ). There were no statistically significant differences between two groups in the time for oxygen therapy and ICU stay time( P >0. 05 ). Conclusion To some extent,the mucosolvan aerosol inhalation is useful for the airway management, and for promoting early rehabilitation of patients after lung cancer surgery.%目的 探讨沐舒坦雾化吸入应用于肺癌术后患者呼吸道管理的影响.方法 将76例肺癌术后患者随机分成两组,每组38例.实验组超声雾化吸入沐舒坦液,对照组常规吸入α-糜蛋白酶液,比较两组患者呼吸道管理效果的差异.结果 与对照组相比较,实验组患者术后吸痰次数减少,住院时间缩短,肺部感染发生率降低,药物不良反应发生率下降,差异均具有统计学意义(P＜0.05);两组患者术后吸氧时间和重症监护时间差异不具有统计学意义(P＞0.05).结论 沐舒坦雾化吸入一定程度上有助于肺癌术后患者呼吸道的管理,促进患者早期康复.
展开▼
